Education
About Us
Working with TipRanks
Follow Us
Theravance Biopharma (TBPH)
NASDAQ:TBPH
Theravance Biopharma (TBPH) Ownership Overview
26.91% Insiders
7.95% Mutual Funds
0.01% Other Institutional Investors
9.76% ETFs
55.35% Public Companies and
Individual Investors
The ownership structure of Theravance Biopharma (TBPH) stock is a mix of institutional, retail, and individual investors. Approximately 17.73% of the company’s stock is owned by Institutional Investors, 26.91% is owned by Insiders, and 55.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 09, 2024 | xxxxxxxxxxxxx | $7798440 | |
| May 03, 2024 | xxxxxxxxxxxxx | $13117335 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $1665 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $342185 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,511,150 | Insider | 19.23% | 87,787,915 | |
| 4,200,021 | Institution | 8.49% | 38,766,194 | |
| 1,939,442 | Institution | 3.92% | 17,901,050 | |
| 1,901,326 | Institution | 3.84% | 17,549,239 | |
| 1,874,611 | Insider | 3.79% | 17,302,660 | |
| 1,584,772 | Institution | 3.20% | 14,627,446 | |
| 417,566 | Institution | 0.84% | 3,854,134 | |
| 412,278 | Institution | 0.83% | 3,805,326 | |
| 393,811 | Insider | 0.80% | 3,634,876 | |
| 374,138 | Insider | 0.76% | 3,453,294 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,584,772 | Institution | 3.20% | 14,627,446 | |
| 417,566 | Institution | 0.84% | 3,854,134 | |
| 412,278 | Institution | 0.83% | 3,805,326 | |
| 366,841 | Institution | 0.74% | 3,385,942 | |
| 232,655 | Institution | 0.47% | 2,147,406 | |
| 200,987 | Institution | 0.41% | 1,855,110 | |
| 183,133 | Institution | 0.37% | 1,690,318 | |
| 118,320 | Institution | 0.24% | 1,092,094 | |
| 111,372 | Institution | 0.23% | 1,027,964 | |
| 102,387 | Institution | 0.21% | 945,032 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,133,837 | Institution | 2.29% | 10,601,376 | |
| 985,016 | Institution | 1.99% | 9,091,698 | |
| 521,635 | Institution | 1.05% | 4,877,287 | |
| 328,977 | Institution | 0.66% | 3,036,458 | |
| 275,319 | Institution | 0.56% | 2,541,194 | |
| 168,179 | Institution | 0.34% | 1,560,701 | |
| 168,089 | Institution | 0.34% | 1,571,632 | |
| 119,907 | Institution | 0.24% | 1,121,130 | |
| 118,088 | Institution | 0.24% | 1,095,857 | |
| 107,880 | Institution | 0.22% | 1,001,126 |
FAQ
Who Owns Theravance Biopharma (TBPH)?
According to the latest TipRanks data, approximately 0.01% of the company's stock is held by institutional investors, 26.91% is held by insiders, and 55.35% is held by retail investors.
What percentage of Theravance Biopharma (TBPH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.01% of Theravance Biopharma (TBPH) stock is held by institutional investors.
What percentage of Theravance Biopharma (TBPH) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.35% of Theravance Biopharma (TBPH) stock is held by retail investors.
Who owns the most shares of Theravance Biopharma (TBPH)?
Eli Samaha owns the most shares of Theravance Biopharma (TBPH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.